Latest news with #Otrivin
Yahoo
11 hours ago
- Business
- Yahoo
Aptar's First Nasal Pump Made with 52% Bio-based Material* now Available with Haleon's Otrivin® Brand
The Freepod® nasal spray pump, globally used with the Otrivin® brand, is now made from 52% bio-based feedstock CRYSTAL LAKE, Ill., July 29, 2025--(BUSINESS WIRE)--Aptar Pharma, a global leader in drug delivery and active material science solutions and services, is proud to announce that its Freepod® nasal spray pump - one of the delivery systems for Haleon's Otrivin® brand - is now made with mass balance bio-based resins. This is the first Aptar delivery system using such materials to be commercialized globally. The use of more sustainable renewable plastic resources is a meaningful measure to help reduce the use of fossil-based materials in healthcare primary packaging. Reinforcing circularity in pharmaceutical packaging Aptar Pharma's Freepod® spray pump used with Haleon's Otrivin® Nasal Spray is made of 52% ISCC Plus certified bio-based feedstock. The bottle is produced using a mass balance approach equivalent to 100% bio-based content. Together, the pump and bottle components result in an overall circular material content of 60% for the full nasal spray device. ISCC PLUS certified manufacturing and supply chain Aptar Pharma is committed to helping its customers meet their sustainability goals, such as reducing the use of fossil-based materials in packaging. The Freepod® nasal spray components are made from bio-based resins derived from renewable feedstocks like bio-waste and residual oils, using an ISCC PLUS-certified mass balance approach. The Aptar Pharma manufacturing site in Mezzovico, Switzerland, is ISCC PLUS certified, ensuring full traceability of materials throughout the manufacturing process and supply chain. ISCC Plus certification also covers all external suppliers - including injection molding providers, service partners, and warehouses - guaranteeing a fully (ISCC) certified supply chain for the Freepod® components. Partnership for a more sustainable approach The joint sustainability approach between Haleon (formerly GSK Consumer Healthcare) and Aptar Pharma is built on a long-term partnership spanning over 30 years. This collaboration has led to significant achievements, including the Otrivin® Freepod® winning the World Packaging Award in 2019 for its innovative and sustainable design. The use of bio-based or renewable feedstocks for the Otrivin® products with Freepod® technology supports Haleon's goal to reduce virgin petroleum-based plastic use by 10% by 2025** and by a third by 2030, compared to 2022 levels. Aptar Pharma's Freepod® for Otrivin®, available globally, demonstrates Aptar's commitment to sustainability and innovation. Looking ahead, this collaboration is anticipated to extend to Otrivin Nasal Mist, Haleon's latest microdroplet technology, which is being rolled out globally since 2023. "At Aptar, sustainability is not just a responsibility - it's a strategic advantage," commented Gael Touya, President of Aptar Pharma. "The launch of Freepod® Futurity™ reflects our commitment to developing solutions that respond to consumers' increasing demand for more sustainable healthcare delivery technologies. As a trusted partner to Haleon, we are proud to help drive the success of the Otrivin® brand while enabling a shift away from fossil-based materials in primary packaging. Supporting our partners in reaching their environmental goals reinforces our vision of supporting the healthcare industry, from Formulation to patient." With a strong commitment to sustainability, Aptar Pharma continuously strives to reduce its environmental impact and support its partners in achieving their sustainability goals. *ISCC Plus certified bio-based feedstock, mass balance approach.**The end point for the goal delivery period is the end of the 2025 calendar year. About Aptar Pharma Aptar Pharma is part of AptarGroup, Inc. (NYSE:ATR), a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions. Aptar's innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world's leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit About Haleon Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding. View source version on Contacts Media Contact: Ciara JacksonAptar Pharma+49 151 1951
Daily News Egypt
01-06-2025
- Business
- Daily News Egypt
Haleon captures over 20% market share in Egypt, locally manufactures 90% of product portfolio
Haleon, the global consumer health leader, has reinforced its footprint in Egypt following its demerger from GSK in July 2022. The company now holds over 20% of Egypt's consumer health market and manufactures approximately 90% of its flagship brands locally, according to Asif Alavi, General Manager for North Africa at Haleon. Speaking to Daily News Egypt, Alavi said that local production covers trusted household names such as Sensodyne, Parodontax, Panadol, Otrivin, and Voltaren Emulgel, underscoring Haleon's commitment to supply chain resilience and economic contribution through technology transfer and export capabilities. Egypt serves as a key regional base for exports to the Maghreb, Gulf countries, and Saudi Arabia. Alavi emphasized that local manufacturing has helped shield the company from global economic volatility, including inflation, currency fluctuations, and supply chain disruptions. 'Our strategy has significantly minimized exposure to global shocks, enabling us to maintain stability and accessibility in the Egyptian market,' he noted. Globally, Haleon is advancing its innovation pipeline, including a £130m investment in a new Global Oral Health Innovation Centre in Weybridge, UK, slated to open in 2027. The facility will support Haleon's category leadership in oral health and accelerate R&D for key brands like Sensodyne, which Alavi described as resilient due to its therapeutic value and strong dentist recommendations—even during economic downturns. Recognizing the price sensitivity in emerging markets, Haleon has adopted a multi-format, tiered pricing strategy to ensure broad accessibility. The company also champions self-care as a cornerstone of sustainable healthcare. Alavi cited research by the Global Self-Care Federation, which estimates self-care interventions have already delivered $119bn in global healthcare cost savings and $1.9trn in welfare gains—figures projected to rise to $179bn and $2.8trn, respectively. Looking ahead, Alavi reaffirmed Haleon's long-term vision in Egypt: 'We are committed to being a core contributor to the Egyptian healthcare ecosystem—by making everyday health more accessible, inclusive, and sustainable.'
Mid East Info
05-05-2025
- Business
- Mid East Info
Özlem Kaynak to lead Haleon's Middle East and Africa Operations as Region Prioritizes Self-Care - Middle East Business News and Information
Dubai, United Arab Emirates, May, 2025: Haleon, a global leader in consumer healthcare and home to brands including Panadol, Sensodyne, Parodontax, Voltaren, Otrivin, and Centrum, has named Özlem Kaynak as its new General Manager for the Middle East & Africa (MEA) Business Unit, effective May 1st. This appointment highlights Haleon's commitment to strengthening its leadership team and global market presence. Özlem's appointment comes at a time when the Middle East and Africa region is placing a growing emphasis on self-care and preventive health, in alignment with Haleon's commitment to delivering accessible health solutions to consumers. Based in Haleon's MEA regional hub office in Dubai, she will be responsible for driving the company's growth strategies and enhancing operations across more than 45 countries. These include Turkey, the Gulf & Near East (including the United Arab Emirates and adjoining countries), Pakistan, Kenya, South Africa, Egypt, and Saudi Arabia and others. Formerly overseeing the Central Eastern Europe (CEE) cluster including Romania, Hungary, Slovakia and Czech Republic. Özlem holds over 25 years of experience in the industry; her previous roles include positions at GSK Consumer Healthcare, Omega Pharma Perrigo, and NIVEA Beiersdorf, where she gained expertise in general management, marketing, and sales. 'I am thrilled to take on the responsibility of leading Haleon MEA — a strategically important region for driving global healthcare innovation,' commented Kaynak. 'I am particularly eager to collaborate with our partners and stakeholders to advance the health inclusivity agenda, ensuring that everyone feels empowered to prioritize their everyday health. I look forward to working with our teams as we support the region's wider healthcare ambitions and national well-being strategies.' Özlem's role will be focused on deepening market presence and unlocking equitable access to better everyday health for all. Her appointment reaffirms Haleon's efforts to increase the representation of women in leadership roles in healthcare. About Haleon: Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories – Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands – such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, Parodontax and Centrum – are built on trusted science, innovation and deep human understanding.
Reuters
30-04-2025
- Business
- Reuters
Haleon first-quarter organic revenue growth beats estimates
April 30 (Reuters) - British consumer healthcare group Haleon's (HLN.L), opens new tab first-quarter organic revenue growth beat expectations on Wednesday as strong growth in oral health products offset weakness in respiratory health and digestive health products. Organic revenue for the three months ending March 31 grew 3.5%, and analysts were expecting a growth of 3.2%, according to a company-compiled consensus. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here. Growing demand for Haleon's oral hygiene products, which includes Sensodyne and Parodontax, helped cushion the impact of lower revenue from its respiratory health and digestive health portfolio that include products like Otrivin and ENO. Haleon reaffirmed its 2025 guidance and said it continues to expect the macroeconomic environment to remain "challenging and uncertain".
News18
28-04-2025
- News18
Uber Driver Turns Car Into ‘1 BHK', Internet Applauds His Hospitality
Last Updated: One of the most notable features of this cab ride was that it came with a Wi-Fi connection. The driver attached a board explaining that Wi-Fi was available inside the car for free. The internet is full of stories about cab ride experiences, ranging from safety concerns and scams to hilarious anecdotes and even viral videos. These stories often highlight the difficulties encountered by passengers, the different behaviours of drivers and the significance of safety precautions. But recently, a woman's cab ride turned out to be one of her best commuting experiences as it felt like travelling in a '1 BHK.' Taking to X, a woman dropped a couple of inside pictures from her cab, booked on Uber, which came so well-equipped, she compared it to living in a one-bedroom apartment. 'Literally travelling in a 1bhk today. Hands down the coolest Uber ride ever," she wrote in the caption. The snapshots highlighted a well-organised structure inside a car with shelves and holders mounted to the backs of the front seats. The driver had loaded the vehicle with a variety of cold drinks, water bottles, snacks such as chips, toys, basic medicines and even a trashcan, providing passengers with a homelike experience during their ride. Notably, the driver had also put some medicines like Digene, Disprin, Citrizine, Dolo 650 and Otrivin for motion sickness or other emergencies. Another section was set aside for tissues, umbrellas, and even a packet of ready-to-eat munchies. Another picture showcased a donation box attached to the car's roof for children's education. Also, it had several facilities like shoe polish, hair oil, cream and a portable fan. One of the most notable features of this cab ride was that it came with a Wi-Fi connection. Yes! You read that right. The driver attached a board explaining that Wi-Fi was available inside the car for free. The password was written clearly for passengers, adding another layer of hospitality to the ride. Abdul Qadeer, the Uber driver, had also left a feedback log requesting passengers to share their experiences in the book and on the Uber app. Above the driver's seat, a newspaper piece showcasing Abdul's work as an exceptional Uber driver was prominently displayed. Literally traveling in a 1bhk today. Hands down the coolest Uber ride ever! — Akaanksha Shenoy (@shennoying) April 25, 2025 The post instantly went viral on social media, prompting several reactions from them. An X user wrote, 'You're not paying him the fare, you're paying him the rent." Another one wrote, 'That shoe polish is an incredible idea." One of them shared, 'It looks like a full-on house. It is a clear-cut reflection of how good a driver must be. 5-star ratings for him." Travelling in a car with such amenities offers a whole lot of comfort and flexibility while moving.
